Toxoplasmosis and parvovirus B19

Infectious Disease Clinics of North America

Volumn 11, Issue 1, 1997, Pages 55-75

  Alger, L S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE;

BONE MARROW SUPPRESSION; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATURIA; HUMAN; INTRAUTERINE INFECTION; KIDNEY FAILURE; PARVOVIRUS; PRENATAL DIAGNOSIS; RASH; REVIEW; TOXOPLASMOSIS; VIRUS INFECTION;

EID: 0030941011     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70341-X     Document Type: Article

References (96)

1. A.E. Ades Evaluating the sensitivity and predictive value of tests of recent infection: Toxoplasmosis in pregnancy Epidemiol Infect 107 1991 527
2. S.P. Adler A.-M.A. Manganello W.C. Koch Risk of human parvovirus B19 infectionsamong school and hospital employees during endemic periods J Infect Dis 168 1993 361
3. L.J. Anderson Role of parvovirus B19 in human disease Pediatr Infect Dis J 6 1987 711
4. Anderson M.J. B.J. Cohen Human parvovirus B19 infections in United Kingdom 1984-1986 Lancet I 1987 738
5. M.J. Anderson P.G. Higgins L.R. Davis Experimental parvoviral infection in humans J Infect Dis 152 1985 257
6. F.G. Araujo D.R. Guptill J.S. Remington Azithromycin, a macrolide antibiotic with potent activity against Toxoplasrna gondii. Antimicrob Agents Chemother 32 1988 755
7. D. Ashburn R. Evans L.J. Skinner Comparison of relative uses of commercial assays for Toxoplasma gondii IgM antibodies J Clin Pathol 45 1992 483
8. H.R. Basetse E.F. Baker A.D. Steele Possible false-positive results for parvovirus B19 IgM antibodies S Afr Med J 83 1993 441
9. I.M. Bernstein E.L. Capeless Elevated maternal serum alphafetoprotein and hydrops fetalis in association with fetal parvovirus B19 infection Obstet Gynecol 74 1989 456
10. A. Berrebi W.E. Kobuch M.H. Bessieres Termination of pregnancy for maternal toxoplasmosis Lancet 344 1994 36
11. M.H. Bessieres C. Roques A. Berrebi IgA antibody response during acquired and congenital toxoplasmosis J Clin Pathol 45 1992 605
12. Bobic B. D. Sibalic O. Djurkovic-Djakovic High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12 years after primary toxoplasma infection Gynecol Obstet Invest 31 1991 182
13. K.E. Brown N.S. Young J.M. Liu Molecular, cellular and clinical aspects of parvovirus B19 infection Crit Rev Oncol Hematol 16 1994 1
14. T. Brown A. Anand L.D. Ritchie Intrauterine parvovirus infection associated with hydrops fetalis Lancet 2 1984 1033
15. D. Carrington D.H. Gilmore M.J. Wittle Maternal serum alpha-fetoprotein: A marker of fetal aplastic crisis during intrauterine human parvovirus infection Lancet I 1987 433
16. J. Cazenave F. Forestier M.H. Bessieres Contribution of a new PCR assay to the prenatal diagnosis of congenital toxoplasmosis Prenat Diagn 12 1992 119
17. T. Chorba P. Coccia R.C. Holman The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease) J Infect Dis 154 1986 383
18. B.J. Cohen M.M. Buckley The prevalence of antibody to human parvovirus B19 in England and Wales J Med Microbiol 25 1988 151
19. J.A. Conry T. Torok P.I. Andrews Perinatal encephalopathy secondary to in utero human parvovirus B19 (HPV) infection (abstract 736s) Neurology 43 suppl 1993 A346
20. Y.E. Cossart A.M. Field B. Cant Parvovirus-like particles in human sera Lancet I 1975 72
21. J. Couvreur G. Desmonts P. Thulliez Prophylaxis of congenital toxoplasmosis: Effects of spiramycin on placental infection J Antimicrob Chemother 22 suppl B 1988 193
22. F. Daffos F. Forestier M. Capella-Pavlovsky Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis N Engl J Med 318 1988 271
23. B.R. Dannemarm W.C. Vaughan P. Thulliez Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol 28 1990 1928
24. Decoster A. F. Darcy A. Caron Anti-P30 IgA antibodies as prenatal markers of congenital toxoplasma infection Clin Exp Immunol 87 1992 310
25. G. Desmonts J. Couvreur Toxoplasmosis in pregnancy and its transmission to the foetus Bull N Y Acad Med 50 1974 146
26. G. Desmonts J. Couvreur Congenital toxoplasmosis: A prospective study of 378 pregnancies N Engl J Med 290 1974 1110
27. J. Dupouy-Camet M.E. Bougnoux Lavareda de Souza S. Comparative value of polymerase chain reaction and conventional biological tests for the prenatal diagnosis of congenital toxoplasmosis Ann Biol Clin (Paris) 50 1992 315
28. C.K. Fairley J.S. Smoleniec O.E. Caul Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection Lancet 346 1995 1335
29. N. Forsgren E. Gille I. Ljungstrom Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987 Lancet 337 1991 1413
30. B. Fortier E. Aissi F. Ajana Spontaneous abortion and reinfection by Toxoplasma gondii. Lancet 338 1991 444
31. W. Foulon A. Naessens M.P. Derde Evaluation of the possibilities for preventing congenital toxoplasmosis Am J Perinatol 11 1994 57
32. W. Foulon A. Naessens T. Mahler Prenatal diagnosis of congenital toxoplasmosis Obstet Gynecol 76 1990 769
33. S.M. Gillespie M.L. Cartter S. Asch Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum JAMA 263 1990 2061
34. E.W. Godofsky Treatment of presumed cerebral toxoplasmosis with azithromycin N Engl J Med 330 1994 575
35. M.P. Goldman D.L. Longworth The role of azithromycin and clarithromycin in clinical practices Cleve Clin J Med 60 1993 359
36. Gratacos E. Torres P.-J. J. Vidal The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome J Infect Dis 171 1995 1360
37. E.S. Gray R.J.C. Davidson A. Artand Human parvovirus and fetal anemia Lancet I 1987 1144
38. C.M. Grover P. Thulliez J.S. Remington Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid J Clin Microbiol 28 1990 2297
39. N.G. Guerina H.W. Hsu H.C. Meissner Neonatal serologic screening and early treatment for congenital Toxoplasma gondi i infection N Engl J Med 330 1994 1858
40. F. Guidozzi D. Ballot A.D. Rothberg Human B19 parvovirus infection in an obstetric population: A prospective study determining fetal outcome J Reprod Med 39 1994 36
41. H.A. Hadi K.O. Easley J. Finley Clinical significance of human parvovirus B19 infection in pregnancy Am J Perinatol 11 1994 398
42. C.B. Hall F.A. Homer Encephalopathy with erythema infectiosum Am J Dis Child 131 1977 65
43. M.D. Hamon A.C. Newland M.J. Anderson Severe aplastic anemia after parvovirus infection in the absence of underlying haemolytic anemia J Clin Pathol 41 1988 1242
44. D.W. Hershey J.A. McGregor Low prevalence of Toxoplasma infection in a Rocky Mountain prenatal population Obstet Gynecol 70 1987 900
45. Hohlfeld P. F. Daffos Costa J.-M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid N Engl J Med 331 1994 695
46. P. Hohlfeld F. Daffos P. Thulliez Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatment J Pediatr 115 1989 765
47. P. Hohlfeld J. MacAleese M. Capella-Pavlovsky Fetal toxoplasmosis: Ultrasono-graphic signs Ultrasound Obstet Gynecol 1 1991 241
48. R.E. Holliman Congenital toxoplasmosis: Prevention, screening, and treatment J Hosp Infect 30 S 1995 179
49. R.E. Holliman J.D. Johnson G. Constantine Difficulties in the diagnosis of congenital toxoplasmosis by cordocentesis: Case report Br J Obstet Gynaecol 98 1991 832
50. Holliman R.E. Clinical sequelae of chronic maternal toxoplasmosis Rev Med Microbiol 5 1994 47
51. W. Humphrey M. Magoon R. O'Shaughnessy Severe nonimmune hydrops secondary to parvovirus B19 infection: Spontaneous reversal in utero and survival of a term infant Obstet Gynecol 78 1991 900
52. D. Jeannel D. Costagliola G. Niel What is known about the prevention of congenital toxoplasmosis Lancet 336 1990 359
53. Johnson D.R. R.A. Fisher J.J. Helwick Screening maternal serum alphafetoprotein levels and human parvovirus antibodies Prenat Diagn 14 1994 455
54. J.S. Kinney L.J. Anderson J. Fartar Risk of adverse outcomes of pregnancy after human parvovirus B19 infection J Infect Dis 157 1988 663
55. P.D. Knott G.A.C. Welpy M.J. Anderson Serologically proved intrauterine infection with parvovirus BMJ 289 1984 1660
56. W.C. Koch S.P. Adler J. Harger Intrauterine parvovirus B19 infection may cause an asymptomatic or recurrent postnatal infection Pediatr Infect Dis J 12 1993 747
57. W.C. Koch S.P. Adler Human parvovirus B19 infections in women of childbearing age and within families Pediatr Infect Dis J 8 1989 83
58. Koppe J.G. A. Rothova Congenital toxoplasmosis. A long-term follow-up of 20 years Int Ophthalmol 13 1989 387
59. Kurtzman G.J. B. Cohen P. Meyers Persistent B19 parvovirus infection as a cause of severe chronic anemia in children with acute lymphocytic leukemia Lancet 2 1988 1159
60. M. Lappalainen P. Koskela M. Koskiniemi Toxoplasmosis acquired during pregnancy: Improved serodiagnosis based on avidity of IgG J Infect Dis 167 1993 691
61. R. McCabe J.S. Remington Toxoplasmosis: The time has come N Engl J Med 318 1988 313
62. R.E. McCabe S. Oster Current recommendations and future prospects in the treatment of toxoplasmosis Drugs 38 1989 973
63. J. McCauley K.M. Boyer D. Patel Early and longitudinal evaluation of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago collaborative treatment trial Clin Infect Dis 18 1994 38
64. T. McGee C. Wolters L. Stein Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis Otolaryngology 106 1992 75
65. C.M. Morgan R.V. Campo Occular toxoplasmosis Contemporary Ophthalmic Forum 5 1987 193
66. Naides S.J. C.P. Weiner Antenatal diagnosis and palliative treatment of nonimmune hydrops fetalis secondary to fetal parvovirus B19 infection Prenat Diagn 9 1989 105
67. M. Peters K. Nicolaides Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection Obstet Gynecol 75 1990 501
68. Pinon J.M. D. Toubas C. Marx Detection of specific immunoglobulin E in patients with toxoplasmosis J Clin Microbiol 28 1990 1739
69. H.J. Porter A.M. Quantrill K.A. Fleming B19 parvovirus infection of myocardial cells Lancet I 1988 535
70. Public Health Laboratory Service Working Party on Fifth Disease Prospective study of human parvovirus (B19) infection in pregnancy BMJ 300 1990 1166
71. S.P. Rao S.T. Miller B.J. Cohen Transient aplastic crisis in patients with sickle cell disease: B19 parvovirus studies during a 7-year period Am J Dis Child 146 1992 1328
72. J.S. Remington R. McLeod G. Desmonts Toxoplasmosis Remington J.S. Klein J.O. infectious Diseases of the Fetus and Newborn Infant ed 4 1995 WB Saunders Philadelphia 140
73. J.F. Rodis D.L. Quinn W. Gary Management and outcomes of pregnancies complicated by human B19 parvovirus infection: A prospective study Am J Obstet Gynecol 163 1990 1168
74. B.B. Rogers D.B. Singer S.K. Mak Detection of human parvovirus B19 in early spontaneous abortuses using serology, histology, electron microscopy, in situ hybridization, and the polymerase chain reaction Obstet Gynecol 81 1993 402
75. T. Roos J. Martius U. Gross Systematic serologic screening for toxoplasmosis in pregnancy Obstet Gynecol 81 1993 243
76. Schwarz T.F. M. Roggendorf B. Hottentrager Immunoglobulins in the prophylaxis of parvovirus B19 infection J Infect Dis 162 1990 1214
77. A. Selbing A. Josefsson L.O. Dahle Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin Lancet 345 1995 660
78. G.R. Sergeant B.E. Sergeant P.W. Thomas Human parvovirus infection in homozygous sickle cell disease Lancet 341 1993 1237
79. Sergent G.R. A.R. Goldstein B19 virus infection and aplastic crisis Pattison J.R. Parvoviruses and Human Disease 1988 CRC Press Boca Raton, FL 85
80. Sever J.L. J.H. Ellenberg A.C. Ley Toxoplasmosis: Maternal and pediatric findings in 23,000 pregnancies Pediatrics 82 1988 181
81. A.U. Sheikh J.M. Ernest M. O'Shea Long-term outcome in fetal hydrops from parvovirus B19 infection Am J Obstet Gynecol 167 1992 337
82. St Georgiev V: Management of toxoplasmosis Drugs 48 1994 179
83. P. Thulliez F. Daffos P. Forestier Diagnosis of toxoplasma infection in the pregnant woman and the unborn child: Current problems Scand J Infect Dis Suppl 84 1992 18
84. Tiessen R.G. Van Elsacker-Niele A.M.W. C. Vermeij-Keers A fetus with a parvovirus B19 infection and congenital anomalies Prenat Diagn 14 1994 173
85. Torok TJ, Anderson LJ, Gary GW, et al: Reproductive outcomes following human parvovirus B19 infection in pregnancy (abstract 374). In Program and Abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy for Microbiology. 1991, p 328.
86. Torok T.J. Wang Q.-Y. Gary G.W. Jr Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique Clin Infect Dis 14 1992 149
87. J. Walker D.J. Nokes R. Jennings Longitudinal study of toxoplasma seroprevalence in South Yorkshire Epidemiol Infect 108 1992 99
88. H.T. Welland C. Vermeij-Keers M.M.M. Salimans Parvovirus B19 associated with fetal abnormality Lancet I 1987 682
89. C.P. Weiner S.J. Naides Fetal survival after human parvovirus B19 infection: Spectrum of intrauterine response in a twin gestation Am J Perinatol 9 1992 66
90. C. Wilson J.S. Remington S. Stagno Development of adverse sequelae in children with subclinical congenital toxoplasmosis infection Pediatrics 66 1980 767
91. S. Wong M. Hadju R. Ramirez Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis J Clin Microbiol 31 1993 2952
92. Wong S.-Y. J.S. Remington Biology of Toxoplasma gondi. AIDS 7 1993 299
93. Wong S.-Y. J.S. Remington Toxoplasmosis in pregnancy Clin Infect Dis 18 1994 853
94. A.D. Woolf G.V. Campion A. Chishick Clinical manifestations of human parvovirus B19 in adults Arch Intern Med 149 1989 1153
95. Y. Yamakawa H. Oka S. Hori Detection of human parvovirus B19 DNA by nested polymerase chain reaction Obstet Gynecol 86 1995 126
96. P.M. Zadik G. Kudesia A.D. Siddons Low incidence of primary infection with toxoplasma among women in Sheffield: A seroconversion study Br J Obstet Gynaecol 102 1995 608